Reactivation of human herpesvirus-6 (HHV-6) frequently occurs following hematopoietic SCT (HSCT), and has been associated with clinical consequences in many patient populations. HHV-6 reactivation and ...

Before any treatment, each clinician and patient must determine whether the anticipated benefits outweigh the potential toll caused on the body. Study results published in Nature suggest that latent ...

Human herpesvirus-6 (HHV-6) belongs to the herpesvirus family and is categorized into variant A and B (HHV-6A and HHV-6B). Primary HHV-6 infection in children and its related diseases are almost ...

Pneumonia is a major problem for patients undergoing bone marrow transplants. Despite testing for specific pathogens, up to 10% of transplant recipients are diagnosed with “idiopathic pneumonia ...

Human herpesvirus 6B (HHV-6B) glycoprotein complex which consists of gH/gL/gQ1/gQ2 is an effective vaccine candidate for HHV-6B. Currently, there is no prevention or treatment for HHV-6B infection.

Serologic studies indicate that human herpesvirus 6 (HHV-6) infects 90 percent of children by two years of age. Little is known about the acquisition, virologic course, and clinical manifestations of ...

Research into inherited human herpesvirus 6 identifies origins in a small number of people thousands of years ago and highlights the potential to 'reactivate.' An international study of integrated HHV ...

Childhood viruses that infect almost everyone and lie dormant in the body for life might be involved in Alzheimer’s disease, researchers reported Thursday. They found that viruses called human herpes ...